![1]()
News
Torsemide vs. furosemide in heart failure patients
May 3, 2021
Does the use of torsemide improve clinical outcomes when compared with furosemide?
![1]()
News
Higher MI shock survival with NCSI protocol: Final results
April 30, 2021
Final results of the National Cardiogenic Shock Initiative show better survival rates in acute MI shock than seen in previous North American studies, but 1-year mortality remains a problem.
News
No link seen between heart inflammation and COVID shots, CDC says
April 29, 2021
“We have not seen a signal and we’ve actually looked intentionally for the signal in the over 200 million doses we’ve given,” says CDC director Rochelle Walensky.
![1]()
News
Being overweight ups risk of severe COVID-19 in hospital
April 29, 2021
This research “adds to the known data on the associations between obesity and severe COVID-19 disease and extends these findings” to patients who are overweight and/or have diabetes.
News
Infective endocarditis from IV drug use tied to hemorrhagic stroke
April 27, 2021
The incidence of patients with IVDU-associated endocarditis increased 630% from 2014 to 2018.
![1]()
News
Efficacy and safety of daily low-dose colchicine after recent MI
April 26, 2021
Can giving low-dose colchicine to patients after a recent myocardial infarction reduce future ischemic cardiovascular events, compared with placebo?
![1]()
News
Lower target LDL-C cuts risk of CV events in ischemic stroke patients
April 23, 2021
Is a target LDL cholesterol (LDL-C) level of less than 70 mg/dL superior to a target LDL-C level of 90-110 mg/dL in prevention of future cardiovascular (CV) events in patients with a prior stroke of atherosclerotic origin or transient ischemic attack (TIA)?
![1]()
News
COVID plus MI confers poor prognosis; 1 in 3 die in hospital
April 22, 2021
National registry data confirm the challenges and uniqueness of patients with STEMI and COVID-19, with atypical symptoms and ‘very high’ in-hospital mortality rates.
![1]()
News
Assessing the efficacy and safety of dapagliflozin in patients with HFrEF
April 22, 2021
Can the use of dapagliflozin, in addition to guideline-directed medical therapy, improve patient-reported outcomes and health-related quality of life in patients with heart failure and reduced ejection fraction (HFrEF)?
![1]()
News
Pneumonia risk soars in heart failure patients, especially HFpEF
April 19, 2021
An analysis of two large trials found that patients with heart failure have an elevated risk of pneumonia and related adverse cardiovascular events.
